Association of BoLA-DRB3.2 Alleles with BLV Infection Profiles (Persistent Lymphocytosis/Lymphosarcoma) and Lymphocyte Subsets in Iranian Holstein Cattle

• Published in: Biochemical genetics 2016-04, Vol.54 (2), p.194-207
• Main Authors: Nikbakht Brujeni, Gholamreza, Ghorbanpour, Reyhaneh, Esmailnejad, Atefeh
• Format: Article
• Language: English
• Subjects: Alleles; Animals; Biochemistry; Biomedical and Life Sciences; Biomedicine; Bovine leukemia virus; Cattle; Disease Resistance - genetics; Enzootic Bovine Leukosis - blood; Enzootic Bovine Leukosis - classification; Enzootic Bovine Leukosis - genetics; Genetic Variation; Histocompatibility Antigens Class II - genetics; Histocompatibility Antigens Class II - isolation & purification; Human Genetics; Immune response; Infectious diseases; Iran - epidemiology; Leukemia; Leukemia Virus, Bovine - isolation & purification; Lymphocyte Subsets - immunology; Lymphocytes; Lymphocytosis - blood; Lymphocytosis - veterinary; Medical Microbiology; Odds Ratio; Original Article; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Regression analysis; Retroviridae; Zoology
• ISSN: 0006-2928; 1573-4927
• DOI: 10.1007/s10528-016-9712-6

Major histocompatibility complex (MHC) is the best-characterized genetic region associated with resistance and susceptibility to a wide range of diseases. In cattle, the most important example of the relationship between the MHC and infectious diseases has been established by the resistance to Bovine leukemia virus (BLV) infection. The association of the bovine MHC class II BoLA-DRB3.2 alleles with BLV infection profiles was examined. BoLA-DRB3.2 allelic diversity was determined in 190 Iranian Holstein cattle using direct sequencing method. Association of the DRB3.2 alleles with BLV infection profiles was found as the odds ratio. Effects of the alleles on lymphocyte subsets were also evaluated by multivariate regression analysis and GLM procedures. The studied cattle were categorized into three groups: BLV seronegative, BLV seropositive with persistent lymphocytosis (PL), and BLV seropositive with lymphosarcoma (LS). The PL profile was significantly associated with the BoLA-DRB3.2*0101, *1101 and *4201 alleles, although the *3202 allele mediating resistance to PL was observed. Significant association was found between the BoLA-DRB3.2*1802, *3202, and *0901 alleles and susceptibility to LS, while the *0101 and *1101 alleles were associated with resistance to LS. BoLA-DRB3.2 alleles also showed a significant correlation with CD4, CD8, CD21 cells and CD4/CD8 ratio. Allelic differences influence the immune response to BLV infection and developing the disease profile. These differences also have important consequences for tumor resistance.